Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Fufang Shuanghua Pian (Compound Shuanghua Tablets) is an approved Traditional Chinese Medicine (TCM) formulation developed and manufactured by Shaanxi Kanghui Pharmaceutical. It is composed of four primary herbal active ingredients: *Lonicera japonica* (honeysuckle), *Forsythia suspensa*, *Andrographis paniculata*, and *Isatis indigotica*. The drug is indicated for clearing heat, detoxifying, relieving throat pain, and reducing swelling. It is specifically used to treat wind-heat external contraction (common cold) and wind-heat tonsillitis, which manifest as fever, headache, nasal congestion, sore throat, and red, swollen tonsils. As a TCM product, its therapeutic effect is derived from the synergistic action of its multiple herbal components rather than a single molecular biological target.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Fufang Shuanghua Pian.